Introduction
Bone marrow-derived cells are important in the formation of new blood vessels in both physiologic and pathologic processes. Several populations of hematopoietic cells assume an endothelial phenotype when cultured under pro-angiogenic conditions. These include CD34+, Sca1+, CD133+, and CD14+ cells (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Additionally, these cells incorporate into growing vasculature in experimental models (3, (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . This expanding body of evidence suggests a critical link between the ability of hematopoietic cells to adopt endothelial characteristics and the processes of blood vessel growth and repair. In vitro systems for the culture of brain microvascular endothelial cells have been developed in which many of the properties of BBB endothelial cells can be maintained.
Cultured brain microvascular endothelial cells can form a tight cellular barrier that develops a high trans-endothelial electrical resistance, impedes the passage of larger
For personal use only. on . by guest www.bloodjournal.org From molecules across the cellular layer, and has enzymatic activities associated with in vivo BBB endothelial cells (33, 38, (44) (45) (46) (47) (48) (49) . These in vitro systems also maintain some of the regulatory properties of the in vivo BBB such as an increase in barrier permeability mediated by vasoactive substances such as bradykinin and histamine (50) (51) (52) .
We hypothesized that if cells of hematopoietic origin could express endothelial cellular markers, they may also be able to carry out other important endothelial functions.
To that end, we now demonstrate that a population of peripheral blood-derived monocytes adopt endothelial characteristics including the formation of a regulated vascular barrier and migrate to damaged vasculature at sites of brain injury. These data suggest an important role for monocytes in repair of the cerebral vasculature.
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Materials and Methods
Cell Culture. Leukopacks from consenting normal donors were obtained from the NIH blood bank or from the New Brunswick affiliated Hospitals blood bank. Mononuclear cells were isolated using histopaque-1077 density separation (Sigma, St. Louis, MO). CD14+ cells were isolated using anti-CD14 magnetic beads according to the manufacturer's instructions (Miltenyi, Auburn, CA). CD14+ cells were then plated at a density of 1-2 x 10 7 cells / 80 cm 2 Throughout this process the media was changed every 3 to 5 days. Whole human bone marrow was obtained from All Cells (Berkeley, CA) and plated at a density of 2 x 10 7 cells per 80cm 2 .
The human bone marrow cells were cultured in conditions identical to those used to generate ELMCs as described above. Mouse brain microvascular endothelial cells were isolated from Cr:NIH(S) (Swiss) mice (NCI, Frederick, MD) as previously described (38, 44 added to the upper chamber of the Transwell to a concentration of 0.5 mg/ml and samples were taken of the buffer in the lower chamber over time. Fluorescence measurements were made using a Victor 2 1420 multilabel counter (Perkin Elmer, Boston, MA) and the concentration of dextran determined. Known concentrations of FITC-labeled dextrans were used to construct concentration curves for fluorescence for both 4kD and 20kD FITC-dextrans. The concentration of FITC-dextran in the upper and lower chambers was determined by fluorescence measurements of the chamber solutions using these curves. Permeability coefficients were calculated as previously described (38) . Briefly, the permeability surface product (PS) was determined using the equation ΔCl/Δt where ΔCl is the incremental clearance volume and Δt is time. ΔCl is determined by multiplying the fraction of compound transferred from donor to acceptor compartment at a time point by the volume of the donor chamber. The permeability coefficient (P) was calculated using the equation PS/S=P where S is the filter surface area. To correct for the contribution of the filter, P was also determined for a fibronectin coated filter and the permeability coefficient for the cell layer alone was calculated using the equation 1/Pc = 1/PtFor personal use only. on July 15, 2017. by guest www.bloodjournal.org From 1/Pf where Pc is the permeability of the cell layer, Pt is the permeability of the total system and Pf is the permeability of the filter.
Enzymatic Assays. Cells in culture were rinsed three times with phosphate buffered saline and then scraped from the culture surface in a minimal volume of ice-cold lysis buffer (0.1% Triton X-100 in PBS). The cells were then stored at -80° C until enzyme activity was assayed. Just prior to assay, cells were rapidly thawed at 37° C and cell debris spun down at 10,000 x g for 10 minutes at 4° C. The supernatant was used in the enzyme assays. γ-Glutamyl transpeptidase (γ-GT) and alkaline phosphatase (ALP) activities were determined using diagnostic assay kits 
Incorporation of ELMCs into repairing vasculature after brain injury. Cold injury was
performed on SCID mice as described previously (53) . Briefly, mice were anesthetized using a combination of ketamine (100mg/kg) and xylazine (4mg/kg) IP. The skull was then exposed.
Under stereotaxic guidance a metal rod 4mm in diameter that had been cooled to -80° C in dry ice was applied to the skull 2mm lateral and 1mm anterior to the bregma. The probe was applied for 30 seconds. ELMCs, freshly isolated human CD14+ peripheral blood mononuclear cells, or CD14-depleted human peripheral blood mononuclear cells were labeled with Cell
Tracker DiI (Molecular probes, Eugene, OR) according to the manufacturer's instructions.
Twenty-four hours after injury 10 6 DiI labeled human cells were injected into each mouse via tail vein. Mice were sacrificed at either 5 days or 4 weeks after the injury and tissue sections were analyzed.
Incorporation of ELMCs into repairing vasculature after skin injury.
A skin biopsy was performed on SCID mice. Briefly, mice were anesthetized using a combination of ketamine Animal Experiments: All procedures followed in the animal experiments were in accordance with NIH or UMDNJ/RWJMS institutional guidelines and had been approved by the appropriate institutional animal care and use committee.
Statistical Analysis: Results are expressed as mean +/-SEM. Statistical analysis was assessed using the Student t-test. The lower limit of significance was taken as p<0.05.
Results

CD14+ peripheral blood monocytes form a cellular layer with high electrical resistance
in vitro. Various models have been used to study the permeability characteristics of brain microvascular endothelial cells (38, (45) (46) (47) (48) (49) (50) (54) (55) (56) . One well-defined system, the Transwell (Corning), consists of a filter dividing upper and lower chambers. Cells can be cultured on the filter and the movement of drugs and other molecules from upper (apical)
to lower (basolateral) chamber measured. The electrical resistance of a cell layer or trans-cellular electrical resistance (TCER) can also be measured (38, 47, 50) . We utilized The permeability of cellular barriers, including the BBB, can be modulated by a number of vasoactive compounds (52) . In order to determine if the barrier formed by ELMCs could be modulated in a similar way, we evaluated the effect of histamine and bradykinin on the TCER of ELMCs. Confluent ELMC cultures on transwells that had developed a high resistance barrier were prepared. Histamine, bradykinin, or vehicle was applied to both the upper and lower chambers and the TCER was measured over time.
Bradykinin caused a decrease in the TCER by 20% over 30 minutes and histamine a decrease of 30% over 30 minutes (Figure 2 ). The magnitude of the decrease in TCER is comparable to the reported effect of bradykinin and histamine in other in vitro BBB systems (51, 52) 
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The activity of several enzyme systems is elevated in BBB-derived endothelial cells compared to endothelial cells from other locations (32, 33, 38, 47, 55) . Thus, we measured the activity of γ-glutamyl transpeptidase and alkaline phosphatase in ELMCs in order to determine if ELMCs had elevated expression of these BBB-associated enzymes.
γ-glutamyl transpeptidase activity was approximately 3-fold higher in ELMCs compared to monocytes or HUVECs and was similar to the level of γ-glutamyl transpeptidase activity seen in mouse brain endothelial cells ( Figure 3A) . By contrast, ELMCs did not have increased alkaline phosphatase activity compared to freshly isolated monocytes or HUVECs and had significantly lower alkaline phosphatase activity than mouse brain endothelial cells ( Figure 3B ).
Human peripheral blood monocytes express endothelial markers when cultured with pro-
angiogenic cytokines. In order to better define the cellular phenotype of the ELMCs once they had formed an intact barrier, we examined their immunophenotype. ELMCs express the endothelial specific marker von Willebrand factor and were stained with the endothelial specific lectin Ulex europaeus agglutinin-1 (UEA-1) (Figure 4) . Additionally, the cells continued to express markers common to cells of both the monocytic and endothelial lineages such as acetylated LDL uptake and CD31 staining (Figure 4 ). They also retained the expression of the monocyte markers CD14 and CD11b (Figure 4 ).
ELMCs also express the tight junction proteins ZO-1 and occludin, whereas freshly isolated monocytes did not (Figure 4) 2,3, 20-29) . A bone marrow transplant was performed on SCID mice using donor marrow from FVB/NTgN (Tie2-LacZ)182Sato mice. These mice express β-galactosidase driven by the Tie2 promoter specifically in endothelial cells. A stab injury was performed on the mice one month following transplantation. Three to five days after the injury the mice were sacrificed and sections of the injured brain were stained for β-galactosidase and endothelial markers. Bone marrow-derived cells were present, and incorporated into the vasculature in the area of injury ( Figure 5 ). Thus, hematopoietic cells appear to participate in repair of the vasculature in the brain.
Labeled ELMCs localize to vasculature at sites of injury.
To more directly demonstrate the homing of ELMCs to the repairing cerebral vasculature two distinct injury models were used. Initial experiments used a stab injury model in SCID mice.
Twenty-four hours after injury DiI labeled human ELMCs were injected via tail vein and three to five days later the animals were sacrificed and brains sectioned and stained for endothelial markers. DiI labeled cells localized to repairing vasculature at sites of brain injury and were seen in a perivascular location ( Figure 6A-C) .
To more completely assess the time course and microanatomical location of the ELMCs after injury, a cold injury model was employed. One day after cold injury, labeled human ELMCs, freshly isolated monocytes, or freshly isolated CD-14 depleted
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From cells were injected via tail vein. Mice were sacrificed at either 5 days or four weeks after injury. Five days after injury labeled ELMCs were present at the injury site. The majority of cells were located at the periphery of the injury with only rare labeled cells seen in areas of uninjured brain ( Figure 6D ). Labeled cells could be found in both a perivascular location and in positions more distant from vessels. A similar pattern was seen with uncultured human CD14+ cells ( Figure 6D ). However, only rare labeled CD-14 depleted cells were apparent at the injury site. At four weeks after injury neither labeled ELMCs nor newly isolated CD14+ cells were present at the injury site, suggesting that these cells are present transiently during vessel repair.
In order to determine the distribution of injected ELMCs to other organs the liver, spleen, and lungs of experimental animals were collected. Labeled ELMCs were present in the spleen but were not observed in the lungs or liver (data not shown).
The ability of ELMCs to form a high resistance barrier suggests that they may have a specific role in brain vasculature. We therefore investigated the ability of ELMCs to home to a site of injury outside of the brain. Skin biopsies were performed on SCID mice and one day after biopsy labeled ELMCs were injected via tail vein. The mice were sacrificed five days after injury and the skin injury site was sectioned. Labeled ELMCs could also be seen in the area of the skin injury ( Figure 6E ). This suggests that the ELMC phenotype is not specific to the central nervous system.
Discussion
Recent studies have documented the critical role of hematopoietic cells in vascular growth and repair. Bone marrow-derived endothelial-like cells incorporate into
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From vasculature following ischemic injury to various organs including the heart (57-60), limb (3, 7, 20, 61, 62) , retina (21) , and brain (29) and also participate in the formation of tumor vasculature (2, 3, 20, 22, 25) . The magnitude of this contribution has been estimated to be between 2 and 20% (26, 62, 63).
Two broad categories of circulating cells with the capacity to assume endothelial traits have been described (63, 64) . Cells expressing hematopoietic progenitor markers such as CD34 and CD133 with a high proliferative capacity and the ability to differentiate into mature endothelial cells have been variously categorized as endothelial progenitor cells (EPC) (24, 15, 13) and outgrowth endothelial cells (64) . EPCs express endothelial-specific proteins such as VE-Cadherin and do not express myeloid markers such as CD45 and CD14. They also have the capacity to incorporate into growing vasculature (7) . Cells of the monocyte/macrophage lineage also express endothelial markers when cultured in the presence of pro-angiogenic cytokines (6-8, 12, 16, 19,64) .
However, as our data as well as that of others show, they maintain expression of monocyte markers such as CD14 and CD45 (6, 19, 64, 67) . The continued expression of myeloid proteins implies that the cells do not trans-differentiate into mature endothelial cells, but rather take on specific endothelial characteristics while remaining inherently monocytic cells. These findings suggest an expanded functional repertoire for monocytes.
Several lines of evidence implicate endothelial-like monocytes in angiogenesis.
In addition to expressing endothelial markers, monocytes cultured with proangiogenic cytokines localize to injured vasculature after intravenous injection (7) and produce angiogenic growth factors that may act as a stimulus for endothelial cell proliferation (16) . They may also play an important role in "drilling" tunnels for new vasculature (65, 66) and are able to adhere to injured vessel walls and accelerate re-endothelialization (68) . Our data add participation in a physiologically regulated blood/tissue barrier to the possible role of monocytes and macrophages in vessel growth.
The ability of CD14+ cells to produce a barrier with a low permeability is unexpected. While comparable to the in vitro barrier formed by mouse brain microvascular endothelial cells, there are important differences between these two cell types. ELMCs form a stringent barrier in the presence of concentrations of VEGF that would be expected to disrupt the BBB (39, 51) and have a lower level of alkaline phosphatase expression. Other in vitro blood brain barrier studies use manipulations such as serum starvation and co-culture with astrocytes to obtain significantly higher TCER (34, 35, 38, 46, 47) . The response of the ELMC barrier to similar conditions remains an area for further study. Additionally, ELMCs localize to sites of injury both inside and outside of the CNS, suggesting that the role of ELMCs in vascular repair is not limited to the brain.
The potential pitfalls of an immunocompromised murine model necessitate that the in vivo data be interpreted with caution. However, taken together, the localization of ELMCs to injury sites in a time frame corresponding to reformation of the BBB, their presence in a perivascular location, and in vitro evidence demonstrating the ability of these cells to form a cellular barrier suggests that they are involved in repair of the vasculature after injury. The homing of un-manipulated CD14+ cells to injury sites implies that peripheral blood monocytes localize to injury sites initially and are then exposed to proangiogenic stimuli and develop endothelial-like characteristics. The In summary, we show that peripheral blood monocytes form a cellular barrier in vitro with a high TCER and low permeability to larger molecules that is responsive to physiologic stimuli such as bradykinin and histamine. We also provide evidence that monocytes may function in vivo in this capacity by demonstrating that cells from both transplanted bone marrow and exogenously cultured ELMCs localize to repairing vasculature. Thus, a previously unrecognized function of monocytes (or a monocyte subpopulation) may be their participation in the formation of a blood-tissue barrier, a function that has traditionally been within the exclusive domain of endothelial cells.
More work is required to better define the importance of this phenotype in normal physiology. 
Figure Legends
Figure 6
ELMCs participate in vascular repair after brain injury. Stab brain injury was performed on SCID mice and DiI-labeled ELMCs were administered to mice via tail vein 24 hours after injury. ELMCs will localize to injuries at non-CNS sites. Skin punch biopsy was performed on the backs of SCID mice. DiI-labeled ELMCs were administered to mice via tail vein 24 hours after injury. Five days after injury the mice were sacrificed and sections through the area of injury were obtained. DiI-labeled ELMCs (red) (E). Nuclei are labeled with DAPI. For personal use only. on July 15, 2017. by guest www.bloodjournal.org From 
